First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer

AIMS: Stereotactic ablative radiotherapy (SABR) for primary renal cell carcinoma (RCC) is a promising non‐invasive ablative treatment option. A prospective interventional clinical trial published showed that treatment was feasible and well tolerated. We present the first single‐institution UK cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarkar, Anjali, Henderson, Dan, Carver, Antony, Heyes, Geoff, Harrop, Victoria, Tutill, Sarah, Kilkenny, Julie, Marshall, Andrea, Elbeltagi, Nada, Howard, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268573/
https://www.ncbi.nlm.nih.gov/pubmed/37334027
http://dx.doi.org/10.1002/bco2.199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268573/
https://www.ncbi.nlm.nih.gov/pubmed/37334027
http://dx.doi.org/10.1002/bco2.199

Ejemplares similares